Publications by authors named "Teresa Magnes"

16Publications

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.

J Clin Med 2020 Jun 1;9(6). Epub 2020 Jun 1.

Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute, Oncologic Center Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9061663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355487PMC
June 2020

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

J Clin Med 2019 Oct 25;8(11). Epub 2019 Oct 25.

rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, 5071 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8111791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912559PMC
October 2019

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Eur J Haematol 2019 May 28;102(5):437-441. Epub 2019 Feb 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849823PMC
May 2019

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

PLoS One 2018 9;13(11):e0206688. Epub 2018 Nov 9.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206688PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156PMC
April 2019

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Eur J Cancer 2018 04 20;93:69-78. Epub 2018 Mar 20.

IIIrd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.064DOI Listing
April 2018

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Memo 2017 20;10(4):220-223. Epub 2017 Oct 20.

Third Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0358-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725515PMC
October 2017

Fluorouracil and Dihydropyrimidine Dehydrogenase Genotyping.

J Clin Oncol 2016 07 9;34(20):2433-4. Epub 2016 May 9.

Paracelsus Medical University Salzburg; Salzburg Cancer Research Institute; and Cancer Cluster Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.6057DOI Listing
July 2016

Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer.

BMC Cancer 2015 Dec 22;15:996. Epub 2015 Dec 22.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Paracelsus Medical University Salzburg, Muellner Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-2020-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687318PMC
December 2015

Liver toxicity during temozolomide chemotherapy caused by Chinese herbs.

BMC Complement Altern Med 2014 Mar 30;14:115. Epub 2014 Mar 30.

Department of Internal Medicine III, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg, Austria, Müllner-Hauptstrasse 48, Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6882-14-115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994275PMC
March 2014